Coumatetralyl
Coumatetralyl is a rodenticide commonly used to control rat and mouse populations. It is a type of anticoagulant, a substance that prevents blood from clotting, leading to internal bleeding and death in rodents.
History[edit]
Coumatetralyl was first introduced in the 1950s as a safer alternative to other rodenticides that were in use at the time. It was developed by Shell Chemicals, a subsidiary of the multinational oil company Shell Corporation.
Mechanism of Action[edit]
Coumatetralyl works by inhibiting the vitamin K cycle in the body. This cycle is responsible for producing clotting factors that help blood to clot. When this cycle is disrupted, the blood becomes unable to clot, leading to internal bleeding.
Usage[edit]
Coumatetralyl is typically used in bait stations, where rodents consume the poison along with food. It is a slow-acting poison, which allows rodents to return to their nests and die there, reducing the chance of secondary poisoning for predators and scavengers.
Safety and Environmental Concerns[edit]
While coumatetralyl is less toxic to non-target species than other rodenticides, it still poses a risk to pets and wildlife if they consume poisoned rodents or the bait directly. It is also harmful to the environment, as it can contaminate water sources and soil.
Regulation[edit]
In many countries, the use of coumatetralyl is regulated due to its potential impact on non-target species and the environment. In the European Union, for example, it is approved for use only in certain situations and must be used with caution.
See Also[edit]
-
Chemical structure of Coumatetralyl
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
